High frequency of allele-specific down-regulation of HLA class I expression in uveal melanoma cell lines

International Journal of Cancer

Volumn 85, Issue 5, 2000, Pages 697-702

  Hurks, H Monique H ^a   Metzelaar Blok, Jessica A W ^a   Mulder, Arend ^a,b   Claas, Frans H J ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b SVM Found Adv Pub Hlth E   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HLA ANTIGEN CLASS 1;

ARTICLE; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CELL CULTURE; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE FREQUENCY; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA MELANOMA;

ADULT; ALLELES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MHC CLASS I; GENETIC MARKERS; HETEROZYGOTE DETECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE I, RECOMBINANT; INTERFERON-GAMMA, RECOMBINANT; MELANOMA; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0033974272     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000301)85:5<697::AID-IJC16>3.0.CO;2-H     Document Type: Article

References (34)

1. BLOM, D.J.R., LUYTEN, G.P.M., MOOY, C.M., KERKVLIET, S., ZWINDERMAN, A.H. and JAGER, M.J., Human leucocyte antigen class I expression: marker of poor prognosis in uveal melanoma. Invest. Ophthalmol. Vis. Sci., 38, 1865-1872 (1997a).
2. BLOM, D.J.R., MOOY, C.M., LUYTEN, G.P.M., KERKVLIET, S., OUWERKERK, I., ZWINDERMAN, A.H., SCHRIER, P.I. and JAGER, MJ., Inverse correlation between expression of HLA-B and c-myc in uveal melanoma, J. Pathol., 181, 75-79 (1997b).
3. BLOM, D.J.R., SCHURMANS, L.R.H.M., DE WAARD-SIEBINGA, I., DE WOLFF-ROUENDAAL, D., KEUNEN, J.E.E. and JAGER, M.J., HLA expression in a primary uveal melanoma, its cell line, and four of its metastases. Brit. J. Ophthalmol., 81, 989-993 (1997c).
4. DE LA CRUZ, P.O., SPECHT, C.S. and MCLEAN, I.W., Lymphocytic infiltration in uveal malignant melanoma. Cancer, 65, 112-115 (1990).
5. DE. WAARD-SIEBINGA, I., BLOM, D.J., GRIFFIOEN, M., SCHRIER, P.I., HOGENDOORN, E., BEVERSTOCK, G., DANEN, E.H.J. and JAGER, M.J., Establishment and characterization of a uveal melanoma cell line. Int. J. Cancer, 62, 155-161 (1995a).
6. DE WAARD-SIEBINGA, I., CREYGHTON, W.M., KOOL, J. and JAGER, M.J., Effects of interferon alpha and gamma on human uveal melanoma cells in vitro. Brit J. Ophthalmol., 79, 847-855 (1995b).
7. DE WAARD-SIEBINGA, I., HILDERS, C.G.J.M., HANSEN, B.E., DELFT, J.L. and JAGER, M.J., HLA expression and tumor-infiltrating immune cells in uveal melanoma. Graefe's Arch. clin. exp. Ophthalmol., 234, 34-42 (1996a).
8. DE WAARD-SIEBINGA, I., HOUBIERS, J.G.A., HILDERS, C.G.J.M., DE WOLFF-ROUENDAAL, D. and JAGER, M.J., Differential expression of HLA-A and B on uveal melanoma as determined by immunohistology. Ocul. Immunol. Inflam., 4, 1-14 (1996b).
9. DURIE, F.H., CAMPBELL, A.M., LEE, W.R. and DAMATO, B.E., Analysis of lymphocytic infiltration in uveal melanoma. Invest. Ophthalmol. vis. Sci., 31, 2106-2110 (1990).
10. FOISSAC, A., CROUAU-ROY, B., FAURE, S., THOMSEN, M. and CAMBON-THOMSEN, A., Microsatellites in the HLA region: an overview. Tissue Antigens, 49, 197-214 (1997).
11. GARRIDO, F., CABRERA, T., LOPEZ-NEVOT, M.A. and RUIZ-CABELLO, F., HLA class I antigens in human tumors. Adv. Cancer Res., 67, 155-195 (1995).
12. GARRIDO, F., RUIZ-CABELLO, F., CABRERA, T., PEREZ-VILLAR, J.J., LOPEZ-BOTET, M., DUGGAN-KEEN, M. and STERN, P.L., Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunol. Today, 18, 89-95 (1997).
13. GEERTSEN, R.C., HOFBAUER, G.F.L., YUE, F.Y., MANOLIO, S., BURG, G. and DUMMER, R., Higher frequency of selective losses of HLA-A and -B allospecificities in metastases than in primary melanoma lesions. J. invest. Dermatol., 111, 497-502 (1998).
14. + cytotoxic T lymphocytes from choroidal melanoma patients. Cancer Immunol. Immunother., 38, 399-405 (1994).
15. KAGESHITA, T., WANG, Z., CALORINI, L., YOSHII, A., KIMURA, T., ONO, T., GATTONI-CELLI, S. and FERRONE, S., Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens. Cancer Res., 53, 3349-3354 (1993).
16. KAN-MITCHELL, J., LIGGETT, P.E., HAREL, W., STEINMAN, L., NITTA, T., OKSENBERG, J.R., POSNER, M.R. and MITCHELL, M.S., Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients. Cancer Immunol. Immunother., 33, 333-340 (1991).
17. KRAUSA, P. and BROWNING, M.J., A comprehensive PCR-SSP typing system for identification of HLA-A locus alleles. Tissue Antigens, 47, 237-244 (1996).
18. LANG, J.R., DAVIDORF, F.H. and BABA, N., The prognostic significance of lymphocytic infiltration in malignant melanoma of the choroid. Cancer, 40, 2388-2394 (1977).
19. LEGHA, S.S., The role of interferon alpha in the treatment of metastatic melanoma. Semin. Oncol., 24, 24s-31s (1997).
20. LIAO, N.S., BIX. M., ZULSTRA, M., JAENISCH, R. and RAULET, D.H., MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science, 253, 199-202 (1991).
21. METZELAAR-BLOK, J.A.W., JAGER, M.J., HANAFI MOGHADDAM, P., VAN DER SLIK, A.R. and GIPHART, M.J., Frequent loss of heterozygosity on chromosome 6P in uveal melanoma. Human Immunol., (1999). (In press).
22. MULDER, A., KARDOL, M., BLOM, J., JOLLEY, W.B., MELIEF, C.J.and BRUNING, J.W., Characterization of two human monoclonal antibodies reactive with HLA-B12 and HLA-B60 respectively, raised by in vitro secondary immunisation of peripheral blood lymphocytes. Human Immunol., 36, 186-192 (1993).
23. MULDER, A., KARDOL, M.J., NITERINK, J.G.S., PARLEVLIET, J.H., MARRARI, M., TANKE, J., BRUNING, J.W., DUQUESNOY, R.J., DOXIADIS, I. and CLAAS, F.H.J., Successful strategy for the large scale production of HLA monoclonal antibodies. In: D. Charron (ed.), Genetic diversity of HLA, functional and medical implications, pp. 354-356, EDK Publishers, Paris (1997).
24. NATALI, P.C., NICOTRA, M.R., BIGOTTI, A., VENTURO. I., MARCENARO, L., GIACOMINI, P. and RUSSO, C., Selective changes in expression of HLA class I polymorphic determinants in human solid tumors. Proc. nat. Acad. Sci. (Wash.), 86, 6719-6723 (1989).
25. 2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. Proc. nat. Acad. Sci. (Wash.), 94, 13140-13145 (1997).
26. REAL, L.M., JIMENEZ, P., CANTON, J., KIRKIN, A., GARCIA, A., ABRIL, E., ZEUTHEN, J., RUIZ-CABELLO, F. and GARRIDO, F., In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele. Int. J. Cancer, 75, 317-323 (1998).
27. ROSENBERG, S.A., Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today, 18, 175-182 (1997).
28. SADLER, A.M., PETRONZELLI, F., KRAUSA, P., MARSH, S.G., GUTTRIDGE, M.G., BROWNING, M.J. and BODMER, J.G., Low-resolution DNA typing for HLA-B using sequence-specific primers in allele-or group-specific ARMS/PCR. Tissue Antigens, 42, 148-154 (1994).
29. STOPECK, A.T., HERSH, E.M., AKPORIAYE, E.T., HARRIS, D.T., GROGAN, T., UNGER, E., WARNEKE, J., SCHLUTER, S.F. and STAHL, S., Phase I study of direct gene transfer of an allogeneic histocompatibility antigen, HLA-B7, in patients with metastatic melanoma. J. clin. Oncol., 15, 341-349 (1997).
30. STORKUS, W.J., HOWELL, D.N., SALTER, R.D., DAWSON, J.R. and CRESSWELL, P., NK susceptibility varies inversely with target cell class I HLA antigen expression. J. Immunol., 138, 1657-1659 (1987).
31. STREILEIN, J.W., Peripheral tolerance induction: lessons from immune privileged sites and tissues. Transplant. Proc., 28, 2066-2070 (1996).
32. TONKS, S., MARSH, S.G. and BUNCE, M., HLA class I typing study. In: D. Charron and R. Fauchet (eds.), Proceedings of the Twelfth International Histocompatibility Workshop, pp. 199-215, EDK, Paris (1997).
33. VERSTEEG, R., KRUSE-WOLTERS, K.M., PLOMP, A.C., VAN LEEUWEN, A., STAM, N.J., PLOEGH, H.L., RUITER, D.J. and SCHRIER, P.I., Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specific. J. exp. Med. 170, 621-635 (1989).
34. WANG, Z., MARGULIES, L., HICKLIN, D.J. and FERRONE, S., Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression. Tissue Antigens, 47, 382-390 (1996).